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Abstract
The plasma membrane transporters for the monoamine neurotransmitters dopamine, serotonin, and norepinephrine
modulate the dynamics of these monoamine neurotransmitters. Thus, activity of these transporters has significant
consequences for monoamine activity throughout the brain and for a number of neurological and psychiatric disorders.
Gene knockout (KO) mice that reduce or eliminate expression of each of these monoamine transporters have provided a
wealth of new information about the function of these proteins at molecular, physiological and behavioral levels. In the
present work we use the unique properties of magnetic resonance imaging (MRI) to probe the effects of altered
dopaminergic dynamics on meso-scale neuronal circuitry and overall brain morphology, since changes at these levels of
organization might help to account for some of the extensive pharmacological and behavioral differences observed in
dopamine transporter (DAT) KO mice. Despite the smaller size of these animals, voxel-wise statistical comparison of high
resolution structural MR images indicated little morphological change as a consequence of DAT KO. Likewise, proton
magnetic resonance spectra recorded in the striatum indicated no significant changes in detectable metabolite
concentrations between DAT KO and wild-type (WT) mice. In contrast, alterations in the circuitry from the prefrontal cortex
to the mesocortical limbic system, an important brain component intimately tied to function of mesolimbic/mesocortical
dopamine reward pathways, were revealed by manganese-enhanced MRI (MEMRI). Analysis of co-registered MEMRI images
taken over the 26 hours after introduction of Mn
2+ into the prefrontal cortex indicated that DAT KO mice have a truncated
Mn
2+ distribution within this circuitry with little accumulation beyond the thalamus or contralateral to the injection site. By
contrast, WT littermates exhibit Mn
2+ transport into more posterior midbrain nuclei and contralateral mesolimbic structures
at 26 hr post-injection. Thus, DAT KO mice appear, at this level of anatomic resolution, to have preserved cortico-striatal-
thalamic connectivity but diminished robustness of reward-modulating circuitry distal to the thalamus. This is in
contradistinction to the state of this circuitry in serotonin transporter KO mice where we observed more robust connectivity
in more posterior brain regions using methods identical to those employed here.
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Introduction
The dopamine transporter (DAT, SLC6A3) acts to terminate
dopaminergic neurotransmission through reuptake of dopamine
from the synaptic cleft into presynaptic neurons. Dopamine is a
key neurotransmitter that can influence cognition, emotion, and
movement; and many drugs exert their psychotropic effects via
DAT [1,2,3,4,5]. In particular, dopamine plays an important role
in the development and maintenance of addiction [6,7] where
much study has been devoted to its role in reward circuitry
associated with the mesolimbic and mesocortical pathways
[8,9,10,11]. Dopaminergic neurons originate in the ventral
tegmental area (VTA) and substantia nigra compacta (SNc), and
projections to areas including the prefrontal cortex [12], integrate
reward circuitry with executive functions mediated by the frontal
cortex. The mesocortical and mesolimbic projections are part of
the brain ‘‘reward circuit,’’ and are direct targets of psychostim-
ulant drugs of abuse. This circuitry is also implicated in mental
illnesses that include schizophrenia, major depressive disorder, and
attention-deficit hyperactivity disorder [13,14,15]. Interactions
among these, and other, structures are complex, with numerous
opportunities for feedback involving a variety of connections and
neuronal types (GABAergic, glutamatergic, dopaminergic, seroto-
nergic, cholinergic, etc.) [16,17,18]. Mouse models with specific
genetic modifications in the components of these pathways allow
us to probe the ramifications of well-defined alterations with an
eye toward parsing endophenotypes of pathological conditions and
behaviors. Studies of mice with genetic manipulations of DAT
[5,19,20,21] and dopamine (DA) receptors [22,23,24,25] have
provided a wealth of information about the cellular, pharmaco-
logical, physiological and behavioral consequences of these
manipulations.
In this work we link the ends of the molecular-to-behavioral
spectrum using a panel of magnetic resonance imaging methods to
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neuronal circuitry and overall brain morphology in the mouse.
By injecting tracer into the prefrontal cortex, we focus on the
limbic cortical-ventral striatopallidal circuitry that has been
implicated in a number of psychiatric disorders that are thought
to involve changes in reward and executive functions mediated
by the prefrontal cortex (PFC), including addiction [26,27,28,
29,30,31,32]. This work parallels our previous examination of the
serotonin transporter (SERT) KO mouse where significant
differences in the reward circuitry were observed between SERT
KO and WT mice [33]. In particular, we observed more robust
connectivity between the PFC and posterior structures in SERT
KO mice, using methods identical to those used in the present
study.
Magnetic resonance spectroscopy (MRS), manganese enhanced
MRI (MEMRI), and diffusion tensor imaging (DTI) data were
obtained in DAT KO and WT mice using protocols similar to
previous studies with SERT KO mice [33]. Magnetic resonance
spectroscopy (MRS) of the striatum provides information about
levels of several small molecules (e.g. glutamate, glutamine, lactate,
N-acetyl-aspartate, choline, myo-inositol, taurine) that are present
in the brain at millimolar or greater concentrations and can
indicate disease states [34,35,36,37]. MEMRI following stereo-
taxic injection of nanoliter amounts of Mn
2+ into the PFC reveals
active neuronal connections that emanate from the PFC.
Computational co-registration of all the 3D images allows the
determination of statistical parametric maps (SPM) that identify
changes on a voxel-wise basis without the need to define regions of
interest. These results thus provide a comprehensive unbiased
approach to identification of the sites to which Mn
2+ is carried
from the PFC injection site. SPM analysis of intensity versus time
provides information about how Mn
2+ accumulation propagates
from the injection site. Tensor based morphometry [38,39]
provides information about local size and shape. MRI makes
possible 3D views of whole brain at 100 micron resolution, thus
providing quantitative mesoscopic information about how deletion
of DAT modulates metabolite levels, structure, and neuronal
circuitry of executive and reward systems that are relevant to
addiction.
Results
Injection site location and condition
Inspection of MR images recorded an hour after injection
revealed that the center of each injection site fell within a 0.2 mm
radius for all 16 animals. The average injection site (6 standard
deviation) was: x (lateral to the midline) +0.9460.07 mm; y
(anterior-posterior with reference to Bregma) +1.0460.14 mm; z
(dorsal-ventral from the brain surface) 21.2960.21 mm. Histo-
logical examination of the injection site revealed minimal damage
due to the injection procedure (Figure 1), and confirmed that the
appropriate location was injected. Histology also confirmed that
the co-injected retrograde tracer rhodamine-dextran was observed
in the expected locations, such as the amygdale, providing an
additional confirmation that the injections were correctly placed
[40,41] (Supplemental information Figure S1).
Metabolite concentrations
We determined concentrations of metabolites relative to
creatine plus phosphocreatine, which is assumed not to vary
among mice or between the two genotypes, by probing the
striatum of both genotype groups. All spectra were recorded from
a2m m
3 volume centered in the striatum. Relative concentrations
for each metabolite are shown in Table 1. Student’s t-test
indicated that none of the metabolite levels were statistically
different in the DAT KO vs WT littermates (p.0.05 in each case).
Voxel-wise Analysis of Morphometry and Mn
2+
Accumulation
Image alignment allows voxel-wise comparisons in both human
and small animal experiments [33,42,43,44,45,46,47]. Three
separate statistical analyses were performed. The first, to gauge
the extent of anatomical morphometric alterations resulting from
the DAT KO, was done using tensor based morphometry (TBM)
Figure 1. Histological examination revealed minimal damage
at the injection site in the prefrontal cortex. A) Nissl-thionine
stained section through the injection site; B) MRI slice from same animal
as (A) in same location; C) Injection site, boxed region in (A) identified
by imaging the same section shown in (A) for rhodamine-dextran
fluorescence. The dextran fluorescence is easily visible against the
background fluorescence from the Nissl stain. Scale bar for A and B
=1 mm. Scale bar for C =100 mm.
doi:10.1371/journal.pone.0011506.g001
Table 1. Relative metabolite concentrations in striatum of
DAT KO and WT mice are similar.
Metabolite Ratio
DAT KO WT
Choline 0.3060.08 0.3460.15
GABA 0.4160.29 0.560.31
Glutamate 2.0360.79 1.9361.1
Glutamine 0.1460.13 0.1760.15
Lactate 0.5460.36 0.5760.39
Myo-inositol 0.8660.32 0.8360.30
N-Acetyl Aspartate 1.060.68 1.1660.6
Taurine 0.3760.31 0.4560.25
Summary of results from MRS showing metabolite concentrations relative to
creatine plus phosphocreatine.
doi:10.1371/journal.pone.0011506.t001
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DAT KO on tissue structure manifest in altered water diffusional
characteristics. For this analysis, we performed image alignment
and statistical parametric mapping of images of a) fractional
anisotropy (FA) and b) trace of the diffusion tensor (TrD) [48].
Thirdly, to follow the movement of Mn
2+-induced hyperintensity
in the MRI data sets, we performed image alignment and
statistical parametric mapping to compare how DAT KO and WT
mice differed in the time dependence of Mn
2+ accumulation at
locations distant from the injection site.
For the tensor based morphometry analysis, the structural and
isotropic diffusion weighted (iDWI) data sets from DAT KO and
WT mice that were obtained prior to any injections provided
input. Very few voxels displayed deformation tensor indices that
differed between DAT KO and WT mice. At a p,0.001 level of
significance no voxels were significantly different in the logmat
SPM. Only 0.8% of voxels reached this level of significance in the
det SPM.
Fractional anisotropy and trace of the diffusion tensor are two
rotationally-invariant indices derived from the diffusion tensor that
provide information about underlying tissue characteristics
[49,50,51,52,53,54,55,56]. Fractional anisotropy is a scalar
measure of the diffusion anisotropy (i.e. the propensity of water
to diffuse along, rather than perpendicular to, a nerve bundle).
TrD is a measure of the orientation-independent mean diffusivity
of water in the tissue. Figure 2 shows a sagittal slice through the
average of all WT FA data sets (gray background). Green voxels
differ significantly between the DAT KO and WT brain scans. FA
measurements in the corpus callosum, adjacent external capsule
and a small part of cerebellar commissure differed between the two
genotypes at p,0.005. Corpus callosum FA was ,24% less in
DAT KO mice compared with WT mice. The cerebellar
commissure FA was ,35% less in DAT KO mice. No other
regions were significantly different. No differences were found in
the TrD maps of DAT KO compared with WT at p,0.005.
Figure 3 illustrates the results of two procedures: a) aligning all
the DAT KO and WT in vivo MR images then b) calculating the
minimum deformation target (MDT) at each time-point, which
provides an unbiased average. The MDT images preserve the
fidelity of the original images. Anatomical structures are clear and
distinct; ventricles, corpus callosum, hippocampus, internal and
external capsule are all easily identifiable. To provide an unbiased
assessment of the whole brain, we performed statistical parametric
mapping to determine the spatial extent of Mn
2+ accumulation,
detected by Mn
+2-induced signal intensity increase, as a function
of time after injection. Color-coded volumes denote significant
(p,0.00025, uncorrected) increases in intensity from one time
point to the next. Representative slices from the 3 dimensional
data sets are shown in Figures 4, 5 and 6. Videos showing the
entire 3D data sets are available as supplementary information
(Video S1, S2, S3 and S4). For clarity, WT and DAT KO data are
shown separately. The earliest time period comparison is shown in
green (1 hr . pre-injection), the 4 hr .1 hr comparison is shown
in red, the 8 hr .4 hr comparison is shown in yellow, and the
26 hr .8 hr comparison is shown in blue for both DAT KO and
WT mice.
The injection site is highlighted (green). This denotes the
significantly more intense signal induced by injecting Mn
2+ into
the prefrontal cortex (Figures 4, 5 and 6). As the green areas (1 hr
. pre) show in the coronal (Figure 4), sagittal (Figure 5), and
Figure 2. Fractional anisotropy differences between DAT KO
and WT. A para-sagittal slice through the average of all WT FA data
sets (grayscale background) is shown. Voxels that differ significantly
between the DAT KO and WT brain scans at P,0.005 are indicated in
green. Scale bar =500 mm.
doi:10.1371/journal.pone.0011506.g002
Figure 3. The minimum deformation template (MDT) images
preserve the fidelity of the original images. The minimum
deformation target (MDT) demonstrates preservation of the fidelity of
the original images. Note the clarity of anatomical structures. The center
of the injection site in the PFC is 1 mm above these transverse sections,
which are at 2.8 mm below the brain surface. These sections illustrate
the result of aligning all the DAT KO and WT in vivo MR images as
described in Materials and Methods. Hyperintense regions indicate the
location of Mn
2+ as it moves away from the injection site. Scale bar
=1 mm.
doi:10.1371/journal.pone.0011506.g003
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2+ induced hyperintensities spread
outward in an essentially isotropic manner immediately after the
injection to provide a spheroid of hyperintensity in the MR image.
This spreading is likely due to diffusion of the Mn
2+ ion. In DAT
KO mice, hyperintense volume elements are also seen along the
midline immediately below the 4
th ventricle (4V). To check that
the intensity increase near 4V was not due to a single outlier, we
repeated the Student’s t-test parametric map analysis 8 times, each
time dropping a different single sample from the analysis. The
intensity increase near 4V was observed in all the comparisons.
Student’s t-test comparisons of the 4 hr post-injection image
datasets with those recorded at 1 hour reveal widespread changes
(Figures 4, 5 and 6, red areas, 4 hr .1 hr). Ventral to the injection
sites, DAT KO mice display ipsilateral hyperintensity increases
that expand into the ipsilateral motor cortex (M1 and M2), nucleus
accumbens, globus pallidus, much of the striatum, lateral
amygdala, middle anterior thalamus, and small areas farther
posterior to the substantia nigra (see Table 2). Dorsal and
ipsilateral to the injection site, the DAT KO mice showed
increased hyperintensity in parts of the cingulate cortex, anterior
striatum, and near the midline in the thalamus. WT littermates
showed a similar pattern to the DAT KO mice with one
exception: some hyperintensity increase was seen in the subiculum
at more than 3 mm from the midline ipsilateral to the injection
site.
Comparison of the 8 hr images with the 4 hr images shows little
change for the DAT KO with minor increases in the ipsilateral
Figure 4. Coronal sections of statistical parametric maps show
the progression of Mn
2+ accumulation over time. Representative
coronal sections through the statistical parametric maps show the
progression of Mn
2+ accumulation over time. Gray background is pre-
injection MDT, while the green (1 hr . pre-injection), red (4 hr .1 hr),
yellow (8 hr .4 hr) and blue (26 hr .8 hr) overlays indicate areas with
increased intensity (P,0.00025) compared to the preceding time point.
Video in Supplemental Data shows the complete image data sets in for
each genotype (Video S1). Slice locations are indicated relative to
Bregma. Scale bars =1 mm.
doi:10.1371/journal.pone.0011506.g004
Figure 5. Sagittal sections of statistical parametric maps show
the progression of Mn
2+ accumulation over time. Representative
sagittal sections through the statistical parametric maps show the
progression of Mn
2+ accumulation over time. Gray background is pre-
injection MDT, while the green (1 hr . pre-injection), red (4 hr .1 hr),
yellow (8 hr .4 hr) and blue (26 hr .8 hr) overlays indicate areas with
increased intensity (P,0.00025) compared to the preceding time point.
Video in Supplemental Data shows the complete image data set for
each genotype (Video S2). Slice locations are indicated relative to the
midline. Scale bars =1 mm.
doi:10.1371/journal.pone.0011506.g005
Figure 6. Transverse sections of statistical parametric maps
show the progression of Mn
2+ accumulation over time.
Representative transverse sections through the statistical parametric
maps show the progression of Mn
2+ accumulation over time. Gray
background is pre-injection MDT, while the green (1 hr . pre-injection),
red (4 hr .1 hr), yellow (8 hr .4 hr) and blue (26 hr .8 hr) overlays
indicate areas with increased intensity (P,0.00025) compared to the
preceding time point. Videos in Supplemental Data show the complete
image data sets for each genotype (Video S3). Slice locations are
indicated relative to the brain. Scale bars =1 mm.
doi:10.1371/journal.pone.0011506.g006
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displayed hyperintensity increases in both the ipsilateral and
contralateral striatum and thalamus, and ipsilateral substantia
nigra (Figures 4, 5 and 6, yellow areas).
Between 8 hr and 26 hr, hyperintensity increases in the DAT
KO mice were seen both ipsilateral and contralateral to the
injection site in the striatum, accumbens, globus pallidus, and
amygdala. The substantia nigra and mid thalamus had increased
hyperintensities mostly ipsilateral with only small increases
contralateral to the injection site (Figures 4, 5 and 6, blue areas).
In the WT mice, a greater number of areas showed increases:
bilaterally in the striatum, globus pallidus; parts of the somato-
sensory and retrosplenial granular cortices; portions of the
hypothalamus and much of the ventral thalamus. Substantial
enhancement was seen ipsilateral to the injection site in the
substantia nigra while contralateral enhancement was seen in the
cingulate cortex.
Discussion
In this study we have used a panel of magnetic resonance
methods, as well as histological confirmation, to investigate
changes brought about by lifetime genetic deletion of the
dopamine transporter. This study parallels an earlier examination
of the serotonin transporter knockout mouse [33]. Histology
confirmed that stereotaxic injection of 3 nanomoles of Mn
2+ with
fluorescent tracers was minimally invasive and placed in the
desired forebrain location. There was little evidence of toxicity, in
accord with work of Canals and coworkers who found that higher
amounts were required to induce significant astrogliosis and
neuronal cell death (8 and 16 nanomoles of Mn
2+, respectively).
[57].
Neither metabolite concentrations nor anatomical differences
were found between DAT KO mice and their WT littermates.
MRS detectable metabolite concentrations in the striatum were at
similar levels in WT and DAT KO mice. There was thus no
evidence that these animals differ from wildtype mice in neuronal
viability (indicated by NAA), excitatory and inhibitory system
integrity (indicated by Glu and GABA), membrane turnover
(indicated by Cho), or glial volume (indicated by Tau)
[35,58,59,60,61,62,63,64]. Similarly, no differences were observed
for these measures between WT and SERT KO mice in our
previous study [33].
Tensor based morphometry compared DAT KO and WT
brains, based on in vivo pre-injection structural MRI and ex vivo
iDWI data sets. These assessments also revealed few statistically
significant differences between genotypes. Although DAT KO
mice are known to have somewhat smaller brains than WT mice
(consistent with overall smaller body size [65]) within the
constraints of resolution (100 mm) and contrast of the MRI data
used, the TBM analysis indicated little or no gross anatomical
differences between WT and DAT KO mice. Thus, there were no
differences in the size or shape of anatomical structures, no missing
structures, no cerebellar or hippocampal dismorphisms. Using a
combination of manually segmented high resolution MRI and
stereological analysis, Cyr and coworkers [66] observed that the
anterior striatum (but not the posterior striatum) of DAT KO mice
was 9% smaller as compared to wild-type mice. Further, using
histological analysis they found an 18% decrease in the number of
neurons in the anterior striatum of DAT KO mice as compared to
Table 2. Anatomical features highlighted by MEMRI as a function of time after PFC stereotaxic injection.
Anatomical feature 1 hr 4 hr 8 hr 26 hr SERT 25 hr
PFC: prefrontal cortex KO & WT
Cortex (S, M, Cg, M, RS) KO & WT KO (S only) & WT
CP: caudate putamen KO & WT WTIC KOIC &W T IC WT
VP: ventral pallidum KO & WT KOic &W T IC
ACB: nucleus accumbens KO & WT KOic &W T IC WTic
GP: globus pallidus KO & WT KOIC &W T IC KO & WTic
AMG: amygdala KO & WT
TH: thalamus KO & WT WTIC KOic &W T ic
HY: hypothalamus LH KO & WT WTIC KO
SI: substantia innominata WTic
SNr: substantia nigra WT WT KO & WT KOic
MG: medial geniculate nu WT
VTA: ventral tegmental area KO
RN: red nucleus KO
PRN: pontine reticular nucleus KO
MEnt: medial entorhinal cortex WTIC
DpMe: deep mesencephalic nu WT
subiculum WT WT
PAG: periaqueductal gray WTIC
midline near 4V KO
A synopsis of anatomical features highlighted by Mn
2+ MRI as a function of time after injection into the prefrontal cortex. At 26 hrs these anterior cortical areas are
highlighted in the WT mouse: S, M, Cg, and RS. For comparison, the rightmost column (SERT 25 hr) shows features highlighted in our previous SERT KO study at 25 hr
after Mn
2+ injection into the prefrontal cortex [33]. Anatomical features were identified by comparing images like those shown in Figure 4 with standard mouse brain
atlases ([119] and the Allen Brain Atlas [120]). KO: DAT KO; WT: WT control; no subscript: ipsilateral; IC subscript: ipsilateral & contralateral.
doi:10.1371/journal.pone.0011506.t002
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The higher spatial resolution (43 mm) and somewhat better
contrast to noise ratio obtained with the techniques used in the
previous work make it more sensitive to small morphological
changes than the current study.
The fractional anisotropy and the trace of the water diffusion
tensor have been used to gain insight into changes in white matter
tracts and other ordered brain structures [47,67,68]. To further
characterize structural differences between DAT KO and WT
mice we compared FA and TrD images of the two genotypes using
statistical parametric maps. No statistically significant differences
were seen in TrD maps (p,0.005). FA in the corpus callosum and
adjacent external capsule was ,24% less in the DAT KO mice
compared to WT mice (see Figure 2) and a small portion of the
cerebellar commissure had FA ,35% less in the DAT KO.
Although these are relatively small changes, lower fractional
anisotropy could be a result of dysmyelination and/or less order in
the neuronal structures crossing the midline in the DAT KO
compared to WT mice that might indicate altered communication
between the two hemispheres.
MEMRI revealed major differences in the pattern of connec-
tivity between the prefrontal cortex and distal brain regions
between the DAT KO mice and their WT littermates. The
complex statistical parametric maps can be assembled into a
simplified diagram of the anatomical locations occupied as Mn
2+
induced- hyperintensities move from the injection site to more
distant locations in the brain (Figure 7). This schematic diagram
and list of structures in Table 2 reveal that anatomical features
highlighted by Mn
2+ tracing are somewhat different in the DAT
KO mice as compared to WT littermates. Statistical parametric
mapping in the WT mice shows Mn
2+ tracing to the striatum,
thalamus, substantia nigra, and subiculum by 4–8 hr post
injection. By 26 hr post-injection, WT mice showed widespread
MRI intensity increases that encompassed the contralateral
thalamus, several cortical areas (especially the somatosensory
cortex), and more basal anterior structures. Thus, WT mice
display Mn
2+ accumulation reflecting the same connectivity along
the cortico-mesolimbic pathway as has been assessed in classical
tracing work [69,70,71,72]. In contrast to the connections from
the PFC seen in WT mice, in the DAT KO mice Mn
2+ movement
was truncated at 26 hr post injection. In the DAT KO mice at
26 hr post-injection the hyperintensity distribution includes a
substantially smaller subset of the WT distribution and Mn
2+
accumulation failed to reach such posterior structures as medial
entorhinal cortex, deep mesencephalic nuclei, and subiculum.
Thus, deletion of the DAT gene produces alterations in
mesocortical circuitry that originate from the PFC.
The time-course and spatial extent of the circuitry traced out
using MEMRI in the WT littermates of DAT KO mice was
substantially different than that observed for the WT littermates of
SERT KO mice reported in our previous study, although the
reasons for these differences are not clear [33]. The studies of these
two strains use the same injection site and procedure. The genetic
background is similar between the two strains, being comprised of
C57BL/6J and 129Sv alleles. While we have not observed
differences between C57BL/6J and 129X1/SvJ mice using
MEMRI (Jacobs, unpublished results); it is likely that different
combinations of C57BL/6J and 129Sv alleles have become fixed
in each strain. The differences that we identify here do emphasize
the necessity for littermate comparisons in transgenic studies to
control for the effects of genetic background.
As in all studies employing neuronal tracers, interpretation of
the results depends on the properties of the tracer. Mn
2+ is
primarily an anterograde trans-synaptic tracer that is transported
via fast axonal transport and accumulates intracellularly to levels
sufficient to induce increased intensity in T1-weighted MR images
at locations distant from the injection site [73,74,75]. Mn
2+ is an
activity dependent tracer that is taken up by active neurons,
probably via voltage and/or ligand gated Ca
2+ channels
[76,77,78]. There is no known specificity of Mn
2+ for any
particular type of neuron. However, although all active neurons at
the site of injection may have taken up the tracer, the initial
projections observed in this work are likely to arise from the
pyramidal projection neurons of the prefrontal cortex [79].
Studies of DAT KO mice have used a wide variety of
behavioral, pharmacological, physiological, and ultrastructural
measures to suggest that this knockout induces significant adaptive
changes at the synaptic, cellular, and molecular levels. These data
include region-specific changes in various dopamine receptor
densities and altered responses in other neurotransmitter systems
[80,81,82,83,84,85]. Thus, it is reasonable to assume that
differences between DAT KO and WT mice observed in this
study are due to local differences in neuronal circuitry and/or
activity at both the injection site and at distal synapses. Alterations
in transport or intracellular accumulation seem less likely to
explain the observations made in the present report.
At the earliest time-point in our series (1 hr post-injection),
Mn
2+ accumulation is seen in the DAT KO mice on the midline
bordering the base of the fourth ventricle. Such accumulation
could be either a consequence of migration around the brain of
Mn
2+ leaked at the brain surface during the injection procedure or
fast axonal transport through the brain parenchyma. Timing of
passage around or through the cerebrum are both consistent with
appearance of Mn
2+ at this location an hour after its introduction.
Within half hour of introduction into the cisterna magna of the rat,
india ink tracer distributes as far forward as the olfactory bulbs and
along paravascular pathways of the middle cerebral artery and its
branches on the superior surface of the brain [86]. Estimates of
the rate of fast axonal transport range from 2 to 16 mm/hr
[87,88,89,90]. The minimum distance between the injection site
and 4V is 6.5 mm, while the distance measured from the injection
site through the striatum and then onto 4V is 7.5 mm. Thus, even
through the longer more anatomically appropriate pathway, the
rate of transport observed here is within the range of previously
observed rates. Rapid Mn
2+ accumulation in areas near 4V may
indicate active connections from the prefrontal cortex to
periventricular areas below 4V in the DAT KO mouse that are
Figure 7. Schematic representation shows PFC associated
circuits are more robust in WT compared to DAT KO mice.
Major circuits delineated by MEMRI are shown. Red (WT) and blue (DAT
KO) arrows in the schematic diagram indicate Mn
2+ transport in the two
genotypes. Detailed anatomy and timing of Mn
2+ transport are shown
in Table 2.
doi:10.1371/journal.pone.0011506.g007
Neurocircuitry in DAT KO Mouse
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Limited resolution and contrast in the MR images and parametric
maps coupled with the existence of many small nuclei in this area
preclude definitive identification of the specific structures involved.
Over the course of 4 hours, Mn
2+ is transported from the
prefrontal cortex to most of the expected areas in both WT and
KO mice: caudate putamen (CP), globus pallidus (GP), nucleus
accumbens (NAc), thalamus (TH), and substantia nigra (SNr).
These areas represent a large subset of the known connections
between the neocortex and the basal ganglia of the rodent brain
[69,71,72]. There was little change in Mn
2+ accumulation
between 4 hr and 8 hr in the DAT KO (note almost no yellow
areas in DAT KO, Figures 4, 5 and 6). Whereas, in the WT there
are substantial increases, generally ipsilateral, in the striatum,
thalamus, and substantia nigra. All these structures had already
seen Mn
2+ accumulation at the earlier 4 hr time point in both
genotypes. That Mn
2+ continues to accumulate in more posterior
anatomy in the WT and not the KO is further indication of more
robust connectivity in the WT as compared with the KO.
In WT mice extensive differences accrued between 8 hr and
26 hr, while only incremental changes were observed in DAT KO
mice. In DAT KO mice Mn
2+ accumulation was restricted to
structures observed at 4 hr post-injection with expansion within
the striatum and thalamus. Whereas, in WT mice large areas both
ipsilateral and contralateral to the injection site showed hyper-
intensity increases at the later time points. These included areas
highlighted at 8 hr (e.g. striatum and thalamus – see yellow colored
areas in Figures 4, 5 and 6), as well as portions of the cortex
(especially somatosensory and retrospenial cortices) and midbrain
regions extending more posterior to the substantia nigra, medial
geniculate nuclei, medial entorhinal cortex and subiculum. The
lack of widespread Mn
2+-induced hyperintensity in DAT KOs
observed 26 hr post-injection indicates a similarly diminished
general communication among distant brain regions in these mice
compared to WT littermates. Less robust connectivity to more
posterior areas would be a natural consequence of cortical
‘hypofrontality’ and/or a consequence of poorer communication
from the striatum. Interestingly, chronic exposure to any of several
drugs of abuse is associated with reduced activity in the frontal
cortex [7,11,91,92]. The previously observed decrease in the
number of anterior striatal neurons in the DAT KO mouse [66]
would be expected to diminish connectivity to structures
functionally downstream of the striatum, as was observed here.
As the PFC and striatum use, or receive, projections from a
number of signaling systems (dopaminergic, glutamatergic,
gabaergic, serotonergic, noradrenergic, etc.) [72,93,94,95,96,97],
widespread differences in Mn
2+ accumulation at 26 hr between
DAT KO and WT mice are likely to represent of indirect
consequences of alterations in dopaminergic signaling induced
directly by deletion of DAT.
By 26 hr, Mn
2+ had sufficient time to cross many synapses and
to be transported throughout the mouse brain [98]. Thus, the
Mn
2+ induced hyperintensity at 26 hr may have been a reflection
of local activity as well as connectivity, complimenting PET
18FDG uptake studies. Recent PET
18FDG uptake studies in DAT
KO mice indicate differential brain metabolism levels in KO
versus WT mice in both the resting state and after acute cocaine
exposure [92]. DAT KO mice have marginally higher baseline
18FDG uptake in the thalamus and cerebellum compared to WT
mice, while all other areas examined had similar levels of uptake.
Acute cocaine exposure decreased
18FDG uptake in the olfactory
bulb, motor cortex, striatum, hippocampus, TH, and cerebellum
in WT mice, while in DAT KO mice only the TH showed a
significant decrease in glucose metabolism. In comparison, Mn
2+
accumulation from 8 hr to 26 hr observed in WT mice was
substantially more widespread (e.g. cortical regions, ipsilateral and
contralateral TH, and periaqueductal gray areas) than that
observed in DAT KO mice. When basal activity differences are
conflated with connectivity differences, as they are in MEMRI, it is
not surprising that somewhat different patterns emerge in the
MEMRI brain scans compared to techniques that measure basal
metabolism only, such as
18FDG uptake in PET scans.
Nonetheless, these imaging results, taken together, indicate that
the DAT KO brain is both qualitatively and quantitatively
different than the corresponding WT brain, with substantial effects
on the reward pathways that may involve several of the
monoamine systems.
The DAT KO mouse has been suggested to constitute an
animal model of several disorders thought to involve hyperdopa-
minergic function, including schizophrenia [2,99], which would be
consistent with a ‘‘hypofrontal’’ phenotype. To some extent this is
a consequence of altered prefrontal/striatal dopamine function
that arises from the DAT KO. Although basal extracellular
dopamine levels in the striatum are greatly enhanced in DAT KO
mice compared to WT mice, this is not observed in the PFC [100].
This circumstance results in a shift in the balance of dopaminergic
activity, as well as, it would seem, the overall balance of activity
within other portions of the reward circuitry. Thus, there are
substantial differences in Fos-like immunoreactivity between DAT
KO and WT mice after psychostimulant administration. DAT
KO mice show substantially reduced activation of frontal areas
[101] as well as a ‘‘hypofrontal’’ phenotype observable in PET
imaging [92]. Some behavioral changes are also consistent with
this overall picture. For instance, DAT KO mice have deficits in
pre-pulse inhibition of startle that can be ameliorated by dopamine
D2 receptor antagonists [102]. How valid a model the DAT KO
mouse is as an animal model of schizophrenia remains to be seen,
but, in any case, several other findings support the overall picture
described above. The most overt consequence of the DAT KO is
locomotor hyperactivity [103,104] that has been described as
constituting an animal model of attention deficit hyperactivity
disorder [99]. Interestingly, both hyperactivity and impairments of
pre-pulse inhibition of startle in DAT KO mice can be reversed by
stimulant drugs such as cocaine, amphetamine and methylpheni-
date [105,106]. Indeed, in each case the actions of the
psychostimulants were in the opposite direction to that observed
in WT mice: hyperactivity and attentional impairments in WT
mice, and reduced hyperactivity and amelioration of attentional
deficits in DAT KO mice. Importantly, it was shown that the
effects of these drugs on pre-pulse inhibition in DAT KO mice
were actually mediated by NET blockade [106], which presum-
ably acts selectively in the prefrontal cortex (but not the striatum)
to elevate dopamine levels and restore the balance of cortical and
striatal dopamine function. Overall, this literature is consistent
with the present results which indicate reduced fronto-cortical
activity in DAT KO mice, indicating that many DAT KO
phenotypes are not simply the result of increased DA function, but
of the consequent changes in activity within the overall circuitry of
which the dopaminergic projections are just one part.
In this study we employed a panel of magnetic resonance
methods to probe the effects of lifelong deletion of DAT in a
mouse model system. As detected by magnetic resonance methods,
no significant changes in metabolite levels or morphology were
observed in DAT KO mice. In contrast, MEMRI revealed that
DAT KO mice had extensive alterations in the executive portions
of reward circuitry that are intimately involved in addiction, as
well as other psychiatric conditions. Connections originating in the
prefrontal cortex were significantly truncated in the DAT KO
Neurocircuitry in DAT KO Mouse
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‘hypofrontality’, described in behavioral, pharmacological and
neurochemical studies of DAT KO mice. In contrast to the
present results, our previous study of the SERT KO mouse
revealed a generally more robust cortico-limbic circuit compared
to WT mice. These studies indicate that a panel of MR imaging
methods combined with statistical parametric mapping analyses is
a powerful tool for endophenotyping the pathological manifesta-
tions of genetic alterations in executive/reward circuitry.
Materials and Methods
Animals
The line of DAT KO mice used in these experiments has been
described previously [104]. Eight DAT KO mice and eight WT
littermates were used in this study. Mice were mixed male and
female subjects between the ages of 18 and 24 weeks.
Ethics Statement
All protocols involving animals in this work were approved by
the Institutional Animal Care and Use Committee of the
California Institute of Technology.
Stereotaxic Injections
The stereotaxic injection procedure was similar to that
employed by Bearer et al [107]. Mice were anesthetized with
ketamine/xylazine (7.5 mg ketamine plus 5 mg xylazine per kg,
i.p.) and placed in a stereotaxic frame (Kopf Instruments,
Tujunga, CA). 5 nl of 600 mM MnCl2 with 0.5 mg/ml rhoda-
mine dextran-amine (3k) (Molecular Probes/Invitrogen, Eugene,
OR) was injected unilaterally into the right prefrontal cortex
(coordinates x –0.8 mm (from the midline), y +1.9 mm (from
Bregma), z 1.8 mm (from the dorsal surface of the brain) [108])
over 5 minutes using a quartz micropipette (1 mm OD quartz
capillary pulled to approximately 20 micron OD tip) guided by
computer-assisted stereotaxic injector (myNeuroLab.com, Rich-
mond, IL). The animal was immediately placed in the MR scanner
under 0.8% isoflurane anesthetic.
Preparation for ex vivo imaging
Within 10 days after in vivo imaging, animals were sacrificed and
brains fixed via transcardiac perfusion with 4% paraformaldehyde
(PFA) as previously described [47]. After overnight rocking in 4%
PFA at 4uC the mouse head was cleaned of skin, lower jaw, ears
and cartilaginous nose tip and then rocked in 50 ml 0.01% sodium
azide in PBS for 7 days at 4uC. The head was then transferred to a
5 mM solution of gadoteridol (ProhanceH, Bracco Diagnostics Inc,
Princeton NJ) and 0.01% sodium azide in PBS and rocked for 7
days at 4uC prior to MR imaging.
Magnetic Resonance Imaging and spectroscopy
Each animal was scanned before the stereotaxic injection; and
beginning at 0:5460:13, 4:2360:09, 8:1360:06, and
25:4560:48 hours post injection. Times are averages over all
animals 6 standard deviation. We use the midpoint of each 40
minute scan as the ‘‘scan time’’ and for convenience call these the
1 hr, 4 hr, 8 hr, and 26 hr time points. An 11.7 T 89 mm vertical
bore Bruker BioSpin Avance DRX500 scanner (Bruker BioSpin
Inc, Billerica, MA) equipped with a Micro2.5 gradient system was
used to acquire all mouse brain images and spectroscopic data
with a 35 mm linear birdcage radio frequency (RF) coil. For in vivo
imaging the animal’s head was secured in a Teflon stereotaxic unit
within the RF coil to minimize movement and to aid in
reproducible placement. Temperature and respiration were
continuously monitored during data acquisition and remained
within normal ranges. We employed a 3D RARE imaging
sequence [109] with RARE factor of 4, 4 averages, TR/TEeff
=250 ms/12 ms; matrix size of 1606128678; FOV 16 mm
612.8 mm 67.8 mm; yielding 100 mm isotropic voxels with 40
minute scan time.
All in vivo mouse brain magnetic resonance spectroscopy (MRS)
experiments were conducted using Point Resolved Spectroscopy
(PRESS) [110] with a short echo time TE of 7.267 ms, recycle
time of 2.3 seconds, a spectral width of 7 KHz, 4000 data points in
each free induction decay signal (FID), and 128 averages. The
sequence was preceded by a VAPOR water suppression module
[111] interleaved with outer volume saturation. Optimized second
order shimming was done with the FastMap routine [112] in a
5 mm cube centered in the striatum. The PRESS spectra were
then recorded inside a 2 mm
3 volume (8 ml) at the center of the
volume used for shimming.
For ex vivo imaging, two intact heads were secured in a TeflonH
holder and submerged in perfluoropolyether (FomblinH, Solvay
Solexis, Inc, Thorofare, NJ) within a 50 ml vial and imaged. The
ambient bore temperature was maintained at 4uC by thermostat-
ically controlled airflow. Diffusion weighted images were acquired
using a conventional pulsed-gradient spin echo (PGSE) sequence
(TR/TE =300 ms/11.9 ms, 25661506120 matrix, 25.6 mm
615 mm 612 mm FOV, 100 mm isotropic voxel size, 1 average,
d=3 ms, D=5.2 ms, Gd=1125 mT/m, nominal b-factor
=3370 s/mm
2). An optimized six point icosahedral encoding
scheme [113] was used for diffusion weighted acquisitions with a
single un-weighted reference image for a total imaging time of
14.5 hours.
Histology
After DTI imaging, 5 brains were selected for histological
examination, 3 DAT KO and 2 WT littermates. Prior to
processing, each brain was released from the skull, post-fixed 1–
3 days, and then sent to Neuroscience Associates (NSA, Knoxville,
TN) for gelatin embedding and frozen sectioning as described
[33]. All 5 brains were embedded in a single gelatin block and
sectioned in register at 30 mm thickness. Each 12th section was
stained for Nissl-Thionine and an adjacent section mounted in
DAPI-containing anti-quench and mounted for fluorescence
microscopy of the co-injected rhodamine dextran. Sections were
imaged on a Zeiss V8 stereoscope equipped with an Axiocam
running AxioVision 4.8, bright and dark-field illumination and
three fluorescent filter cubes for DAPI, TRITC, and FITC on a
Zeiss Axioscope Z1 with an MRM and HRC Axiocam running
AxioVision 4.6 software and having a similar brightfield and
fluorescence capabilities.
Image Alignment and Statistical Parametric Mapping
Pre- and post-Mn
2+ injection MR images were skull-stripped
using the Brain Surface Extractor (BSE) within BrainSuite2 [114]
to remove all non-brain material. Inaccuracies were corrected by
manually editing the masks using BrainSuite 2. After skull-
stripping, field inhomogeneities were corrected using the N3
method [115] and each was scaled to the mode of its intensity
histogram [107,116,117]. A minimum deformation target (MDT)
was produced from the pre-injection images as described [33,118].
The pre-injection images were then warped into this MDT as
described [33] and the post-injection images were linearly aligned
(12 parameter model) to the pre-injection images using Align-
linear, followed by application of the polynomial warp field used to
transform that sample’s pre-injection image into the MDT. Final
images were blurred with a 0.3 mm Gaussian kernel and a paired
Neurocircuitry in DAT KO Mouse
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intensity when comparing one time point to the next. Similar
processing was used to compare rotationally invariant indices
derived from DTI datasets, except that an unpaired Student’s t-
test was used to compare DAT KO and WT mice. Parametric
maps of voxels with statistically significant changes in intensity
were created to display the results and to correlate increases with
underlying anatomy [107]. Anatomy was determined with
reference to Hoff et al. [119] and the Allen Brain Atlas [120]
(http://www.brain-map.org/welcome.do).
Tensor Based Morphometry
A deformation field analysis implemented by Thompson and
coworkers [121] was used to analyze whether MRI scans of the
DAT KO mice differed anatomically from WT mouse brain scans,
as described [33]. Structural RARE and iDWI data were mapped
to their respective MDTs, the deformation field needed to warp
each image to the WT pre-injection structural or iDWI MDT
determined, and p-value maps calculated noting statistical
significance of differences in the deformation tensors of the two
cohorts as measured by comparisons of the determinant of the
deformation tensor and matrix logarithm of the determinant at
each voxel [39,48,117,122,123].
Determination of relative metabolite concentrations
For each mouse brain the spectrum of the relative amount of
metabolites inside the experimental PRESS volume was quantified
using the QUEST (quantitation based on quantum estimation)
module [124] available inside the Java Magnetic Resonance User
Interface (JMRUI) package [125]. Spin parameters (number of
spins, chemical shifts, J-couplings) were obtained from Govindar-
aju [126]. Metabolite amounts obtained by the QUEST were
normalized to creatine plus phosphocreatine.
Diffusion tensor image construction
Reconstruction of the apparent diffusion-weighted images
included spatial radial Gaussian filtering (0.25 voxel width) to
smooth the co-registration cost-function and improve the SNR of
all subsequent calculations. The apparent diffusion tensor was
calculated conventionally by inversion of the encoding b-matrix.
The b-matrix for each diffusion encoding was determined by
numerical simulation of the pulse sequence k-space trajectory in
order to account for gradient cross-terms [127]. Eigenvalues,
eigenvectors, tensor trace and fractional anisotropy were calculat-
ed conventionally using built-in and custom Matlab functions (The
Mathworks Inc., Natick MA). The six diffusion weighted images
were averaged to generate a high SNR isotropic diffusion weighted
image (iDWI). Diffusion tensor images (and associated images of
eigenvalue, li; trace, TrD; and fractional anisotropy, FA) were
placed into the same space for voxel-wise comparisons using the
methods outlined above for in vivo MR images.
Rendering
Visualization of the MR images and statistical parametric maps
was performed with ResolveRT4 (Mercury Computer Systems,
Inc., Hudson, NH) and MRIcro [128].
Supporting Information
Figure S1 Rhodamine-dextran is transported to the amygdala
in a wild type animal 16 days after injection in the PFC. The
sections was mounted, stained with DAPI for nuclei and imaged
for rhodamine and DAPI fluorescence. Alternate sections were
Nissl stained. A) Rhodamine-dextran appears in the red channel
in neurons of the amygdala and not in other areas in this part of
the brain. The DAPI-stained nuclei are shown in blue. B) Nissl-
stained section adjacent to the section shown in A) which overlaps
the boxed area. These results demonstrate that the location of the
injection site was appropriate for the introduction of tracer into
the expected forebrain-midbrain pathway. The location of the
rhodamine fluorescence is consistent with rhodamine-dextran
having arrived via retrograde transport along the axons to the
neuronal cell body. Scale bar =100 mm.
Found at: doi:10.1371/journal.pone.0011506.s001 (3.23 MB TIF)
Video S1 Coronal sections through the statistical parametric
maps show the progression of Mn2+ accumulation over time.
Gray background is pre-injection MDA, while the colored overlays
denote areas with increased intensity (P,0.00025) at 1 hr (green),
4 hr (red), 8 hr (yellow), and 24 hr (blue) compared to the
preceding time point. Video shows consecutive sections in the
coronal directions for the DAT knockout and wild-type cohorts.
Slice locations are shown at the bottom right in millimeters with
respect to Bregma. Scale bar =1 mm.
Found at: doi:10.1371/journal.pone.0011506.s002 (7.36 MB
MOV)
Video S2 Sagittal sections through time-series statistical parametric
maps. Gray background is pre-injection MDA, while the colored
overlays denote areas with increased intensity (P,0.00025) at 1 hr
(green), 4 hr (red), 8 hr (yellow), and 24 hr (blue) compared to the
preceding time point. Video shows consecutive sections in the sagittal
directions for the DAT knockout and wild-type cohorts. Slice
locations are shown at the bottom right in millimeters with respect to
midline. Scale bar =1 mm.
Found at: doi:10.1371/journal.pone.0011506.s003 (6.34 MB
MOV)
Video S3 Transverse sections through time-series statistical para-
metric maps. Gray background is pre-injection MDA, while the
colored overlays denote areas with increased intensity (P,0.00025) at
1 hr (green), 4 hr (red), 8 hr (yellow), and 24 hr (blue) compared to the
preceding time point. Video shows consecutive sections in the
transverse directions for the DAT knockout and wild-type cohorts.
Slice locations are shown at the bottom right in millimeters with respect
the brain surface. Scale bar =1 mm.
Found at: doi:10.1371/journal.pone.0011506.s004 (5.69 MB
MOV)
Video S4 Three dimensional rotations of statistical parametric
maps. Three dimensional rotations of statistical parametric maps
with Gray background is pre-injection MDA, while the colored
overlays denote areas with increased intensity (P,0.00025) at 1 hr
(green), 4 hr (red), 8 hr (yellow), and 24 hr (blue) compared to the
preceding time point.
Found at: doi:10.1371/journal.pone.0011506.s005 (9.44 MB
MOV)
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